Advertisement

Topics

BMS, Clovis to collaborate on cancer studies

05:17 EDT 1 Aug 2017 | SmartBrief

Bristol-Myers Squibb and Clovis Oncology agreed to combine the former's Opdivo, or nivolumab, and Clovis' Rubraca, or rucapar -More

Original Article: BMS, Clovis to collaborate on cancer studies

NEXT ARTICLE

More From BioPortfolio on "BMS, Clovis to collaborate on cancer studies"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...